These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25368245)

  • 1. The combination of nuclear factor kappa B, cyclo-oxygenase-2 and vascular endothelial growth factor expression predicts poor prognosis in stage II and III colorectal cancer.
    Kim NK; Park JK; Shin E; Kim YW
    Anticancer Res; 2014 Nov; 34(11):6451-7. PubMed ID: 25368245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-existence of cyclin D1 and vascular endothelial growth factor protein expression is a poor prognostic factor for UICC stage I-III colorectal cancer patients after curative resection.
    Tsai HL; Yeh YS; Chang YT; Yang IP; Lin CH; Kuo CH; Juo SH; Wang JY
    J Surg Oncol; 2013 Feb; 107(2):148-54. PubMed ID: 22926658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic significance of nuclear factor-κB and vascular endothelial growth factor expression in advanced gastric cancer patients.
    Park KW; Kim SJ; Oh SY
    Oncol Res Treat; 2014; 37(4):183-90. PubMed ID: 24732642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
    Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
    Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of monocarboxylate transporter (MCT)-4 in colorectal cancer and its role: MCT4 contributes to the growth of colorectal cancer with vascular endothelial growth factor.
    Gotanda Y; Akagi Y; Kawahara A; Kinugasa T; Yoshida T; Ryu Y; Shiratsuchi I; Kage M; Shirouzu K
    Anticancer Res; 2013 Jul; 33(7):2941-7. PubMed ID: 23780984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis.
    Soumaoro LT; Uetake H; Takagi Y; Iida S; Higuchi T; Yasuno M; Enomoto M; Sugihara K
    Dis Colon Rectum; 2006 Mar; 49(3):392-8. PubMed ID: 16474989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
    J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer.
    Noike T; Miwa S; Soeda J; Kobayashi A; Miyagawa S
    Hum Pathol; 2008 Feb; 39(2):201-8. PubMed ID: 17949784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
    Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A
    Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
    Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
    Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multivariate analysis of prognostic determinants for stages II and III colorectal cancer in 141 patients.
    Zhou ZG; Wu XJ; Li LR; Peng ZH; Ding PR; Wang RJ; Pan ZZ
    Chin Med J (Engl); 2011 Jul; 124(14):2132-5. PubMed ID: 21933615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
    Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
    Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of nuclear factor-kappaB in human astrocytomas: relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival.
    Korkolopoulou P; Levidou G; Saetta AA; El-Habr E; Eftichiadis C; Demenagas P; Thymara I; Xiromeritis K; Boviatsis E; Thomas-Tsagli E; Panayotidis I; Patsouris E
    Hum Pathol; 2008 Aug; 39(8):1143-52. PubMed ID: 18495209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological significance of the expression of estrogen receptor-beta and vascular endothelial growth factor-A in colorectal cancer.
    Taggarshe D; Lobocki C; Silberberg B; McKendrick A; Mittal VK
    Am Surg; 2012 Dec; 78(12):1376-82. PubMed ID: 23265127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as a prognostic factor.
    Tamura M; Oda M; Tsunezuka Y; Matsumoto I; Kawakami K; Watanabe G
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):517-22. PubMed ID: 15457151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
    Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor (VEGF) and cyclooxygenase 2 (COX 2) immunostaining in ovarian cancer.
    Whynott RM; Manahan P; Geisler JP
    Eur J Gynaecol Oncol; 2016; 37(2):164-6. PubMed ID: 27172738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of c-erbB-2 and vascular endothelial growth factor in colorectal liver metastases.
    Chen J; Li Q; Wang C; Wu J; Zhao G
    Ann Surg Oncol; 2010 Jun; 17(6):1555-63. PubMed ID: 20069460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclooxygenase-2, vascular endothelial growth factor and matrix metalloproteinase-2 in patients with primary laryngeal carcinoma: a tissue microarray study.
    Dong P; Li X; Yu Z; Lu G
    J Laryngol Otol; 2007 Dec; 121(12):1177-83. PubMed ID: 17888194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.